No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL Oxidation in smokers

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 5, 1998, Pages 833-841

  Princen, Hans M G ^a   Van Duyvenvoorde, Wim ^a   Buytenhek, Rien ^a   Blonk, Cor ^b   Tijburg, Lilian B M ^b   Langius, Jacqueline A E ^c   Edo Meinders, A ^c   Pijl, Hanno ^c  

^a TNO   (Netherlands)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidants; Flavonoids; LDL oxidation; Plasma cholesterol; Tea

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYPHENOL; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CORONARY RISK; DIETARY INTAKE; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; TEA;

EID: 0031833130     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.5.833     Document Type: Article

References (17)

1. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219-225.
2. Shaikh M, Martini S, Quiney JR, Baskerville P, La Ville AE, Browse NL, Duffield R, Turner PR, Lewis B. Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis. 1988;69:165-172.
3. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
4. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887.
5. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis. Arterioscler Thromb. 1994;14:1892-1899.
6. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992;339:1183-1186.
7. De Rijke YB, Vogelezang CJM, Van Berkel TJC, Princen HMG, Verwey HF, Van der Laarse A, Bruschke AVG. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients. Lancet. 1992;340: 858-859.
8. Cominacini L, Garbini U, Pastorino AM, Davoli A, Campagnola M, De Santis A, Pasini C, Faccini GB, Trevisan MT, Bertozzo L, Pasini F, Lo Cascio V. Predisposition to LDL oxidation in patients with and without angiography established coronary artery disease. Atherosclerosis. 1993; 99:63-70.
9. Clifton PM. Antioxidant vitamins and coronary heart disease risk. Curr Opin Lipidol. 1995;6:20-24.
10. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991;337:1-5.
11. Gey KF, Moser UK, Jordan P, Stähelin HB, Eichholzer M, Lüdin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr. 1993;57(suppl): 787S-797S.
12. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993:328:1450-1456.
13. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
14. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracene J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van 't Veer P, Huttunen JK, Martin-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet. 1993;342:1379-1384.
15. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
16. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
17. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.